Chronic myeloid leukaemia as a model of disease evolution in human cancer.
about
Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemiaIdentification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated MechanismRegulation of myeloid leukaemia by the cell-fate determinant MusashiA new view of carcinogenesis and an alternative approach to cancer therapyCould Vitamin D Analogues Be Used to Target Leukemia Stem Cells?The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phaseBMI1: A Biomarker of Hematologic MalignanciesProtein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive LeukemiasIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cellsJAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft ModelsMolecular pathogenesis of peripheral neuroblastic tumorsEffective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanismQuantitative modeling of chronic myeloid leukemia: insights from radiobiologyHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsSustained proliferation in cancer: Mechanisms and novel therapeutic targetsSex differences in the incidence of chronic myeloid leukemiaEmerging Roles of SIRT1 in Cancer Drug ResistanceATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistanceEvolutionary foundations for cancer biologyTKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CMLmiR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability.ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapyReciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.Emerging drugs for chronic myeloid leukemia.Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitorsBCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP.Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.Generation of iPSCs from cultured human malignant cells.Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion.Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.Methylation status of DDIT3 gene in chronic myeloid leukemiaPristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl.Bcl2 is not required for the development and maintenance of leukemia stem cells in mice.Chronic myeloid leukemia: mechanisms of blastic transformationGTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies
P2860
Q21245701-0B725030-2B67-4676-A74B-945C75511D04Q24293171-379FF5CC-58EE-4D1C-877D-4F3490FBD87EQ24626837-3BAA23D3-29FB-4E32-BEED-7C925E3FC10DQ24634359-E091C592-E334-4CD2-AC72-5A922CED0BC4Q24650249-9887D3EB-E53D-4DCC-85BD-56EF1D96886FQ26747513-37DEE632-FDE2-4699-A753-C7D8F767795DQ26749343-65853304-276A-4DF2-9F23-BCB0249F4DE7Q26750676-B4FBF828-0D9F-42C5-A073-3A3A614C1E15Q26769590-6E7FE5F1-ED95-45B4-B525-83D80B020588Q26779702-3CD4CC84-5A22-445E-BDB2-7A07B967A80EQ26828528-AF44D256-72DC-45BD-91FE-28AFC755AFE1Q27012572-D389E2AD-D655-42E6-915E-96BB5F3E0917Q28076328-3DF0B3FE-4558-4D7A-AF0C-341048A8993DQ28271405-A734F12E-2132-47A3-9FAB-15E229C65767Q28275023-EAD687D5-7A3B-4BBB-B097-D0098B215F86Q28384954-4FD54F90-966C-4615-BA8A-2666D30D13B2Q28393898-AE4AC65B-8265-4E90-ACE4-A4F9F4DF961DQ28396388-1F9888A5-A7E0-414A-AC11-855B47B74830Q28396953-088AC486-502A-4C2F-BFFD-D39986EA72A4Q28536892-00E58E26-898E-46F3-8579-992D9DE5F176Q28540033-86FD9295-073C-47BD-8668-8DCA7BE2BDE9Q28709090-D25DB259-0FFF-4D2C-AAD5-D9F70DB3692AQ30357188-DCB3E9D4-DF6E-4286-8458-04FA6631C6E5Q30496174-4BBE1D5B-F799-4A4B-8368-C8322E71D951Q30537656-E139B4AF-1F35-49A7-B15E-177B0EE61297Q33476874-31783B4C-B08B-48E1-8706-ADB6A89C801AQ33513975-423D8892-E133-48BE-9F45-AB0484C564A5Q33524890-B817C78C-8918-4B74-A5A8-C24018C6A567Q33536762-1415B48D-006D-44FB-8D7C-0DD4CAEE9023Q33603379-5866B41C-CBF1-4E18-B21F-15966BA1AD8DQ33727572-1BB217B4-A821-49AE-B118-544BA9E2F85BQ33784347-1A7A20FD-A904-465C-B739-8FFFB171F8D6Q33871512-F8D9A6BE-8A45-459A-9485-2D3B6AD93FE7Q33908547-21125BE5-6972-4EB7-80FA-BADC8BB18DF4Q33919931-B4B41C46-62E3-4814-8C92-B1CB7AF1DB62Q33933648-B716DA00-C89B-473B-A1BB-6C394065CE5FQ33944952-B988ABCA-3FF3-40CE-9CAF-2852DA6646B9Q33947776-C4B08244-362F-4480-ADE6-828E10D3C9EAQ33968037-912327EF-65D8-4254-8950-1998A3DCC5AAQ34081636-A9B112F8-8109-4DE0-B15C-7E7BCD93F307
P2860
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@ast
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@en
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@nl
type
label
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@ast
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@en
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@nl
prefLabel
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@ast
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@en
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@nl
P356
P1476
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
@en
P2093
David J Barnes
Junia V Melo
P2888
P304
P356
10.1038/NRC2147
P407
P577
2007-06-01T00:00:00Z
P5875
P6179
1029023662